| Trial ID: | L0951 |
| Source ID: | NCT01464801
|
| Associated Drug: |
Resveratrol
|
| Title: |
Long-term Investigation of Resveratrol on Management of Metabolic Syndrome, Osteoporosis and Inflammation, and Identification of Plant Derived Anti-inflammatory Compounds, Study 3
|
| Acronym: |
LIRMOI3
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver
|
| Interventions: |
Dietary Supplement: Resveratrol;Dietary Supplement: Placebo
|
| Outcome Measures: |
Change in hepatic steatosis and inflammationAssessment of tolerability and side-effects
|
| Sponsor/Collaborators: |
University of Aarhus
|
| Gender: |
All
|
| Age: |
18 Years70 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
28
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
| Start Date: |
29/09/2011
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
29 June 2015
|
| Locations: |
Denmark
|
| URL: |
http://clinicaltrials.gov/show/NCT01464801
|
